Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-Resistant Lung Cancer.
Xin Q, Ji Q, Zhang Y, Ma W, Tian B, Liu Y, Chen Y, Wang F, Zhang R, Wang X, Yuan J.
Xin Q, et al. Among authors: tian b.
Oxid Med Cell Longev. 2022 Jun 20;2022:1112987. doi: 10.1155/2022/1112987. eCollection 2022.
Oxid Med Cell Longev. 2022.
PMID: 35770045
Free PMC article.